Ascendis Pharma A/S is a biotechnology business based in the US. Ascendis Pharma A/S shares (ASND) are listed on the NASDAQ and all prices are listed in US Dollars. Ascendis Pharma A/S employs 482 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Ascendis Pharma A/S
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ASND – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Ascendis Pharma A/S stock price (NASDAQ: ASND)Use our graph to track the performance of ASND stocks over time.
Ascendis Pharma A/S shares at a glance
|Latest market close||$158.45|
|52-week range||$109.36 - $183.98|
|50-day moving average||$139.56|
|200-day moving average||$134.22|
|Wall St. target price||$192.88|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-10.04|
Buy Ascendis Pharma A/S shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Ascendis Pharma A/S stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Ascendis Pharma A/S price performance over time
|1 week (2021-09-15)||0.72%|
|1 month (2021-08-20)||31.55%|
|3 months (2021-06-22)||13.19%|
|6 months (2021-03-22)||12.25%|
|1 year (2020-09-22)||9.83%|
|2 years (2019-09-20)||44.72%|
|3 years (2018-09-21)||138.27%|
|5 years (2016-09-22)||693.44%|
Ascendis Pharma A/S financials
|Revenue TTM||$5.1 million|
|Gross profit TTM||$7 million|
|Return on assets TTM||-36.88%|
|Return on equity TTM||-78.63%|
|Market capitalisation||$9.2 billion|
TTM: trailing 12 months
Shorting Ascendis Pharma A/S shares
There are currently 2.7 million Ascendis Pharma A/S shares held short by investors – that's known as Ascendis Pharma A/S's "short interest". This figure is 5.5% down from 2.8 million last month.
There are a few different ways that this level of interest in shorting Ascendis Pharma A/S shares can be evaluated.
Ascendis Pharma A/S's "short interest ratio" (SIR)
Ascendis Pharma A/S's "short interest ratio" (SIR) is the quantity of Ascendis Pharma A/S shares currently shorted divided by the average quantity of Ascendis Pharma A/S shares traded daily (recently around 293043.57848518). Ascendis Pharma A/S's SIR currently stands at 9.11. In other words for every 100,000 Ascendis Pharma A/S shares traded daily on the market, roughly 9110 shares are currently held short.
However Ascendis Pharma A/S's short interest can also be evaluated against the total number of Ascendis Pharma A/S shares, or, against the total number of tradable Ascendis Pharma A/S shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Ascendis Pharma A/S's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 Ascendis Pharma A/S shares in existence, roughly 50 shares are currently held short) or 0.0613% of the tradable shares (for every 100,000 tradable Ascendis Pharma A/S shares, roughly 61 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Ascendis Pharma A/S.
Find out more about how you can short Ascendis Pharma A/S stock.
Ascendis Pharma A/S share dividends
We're not expecting Ascendis Pharma A/S to pay a dividend over the next 12 months.
Ascendis Pharma A/S share price volatility
Over the last 12 months, Ascendis Pharma A/S's shares have ranged in value from as little as $109.36 up to $183.98. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Ascendis Pharma A/S's is 0.7969. This would suggest that Ascendis Pharma A/S's shares are less volatile than average (for this exchange).
Ascendis Pharma A/S overview
Ascendis Pharma A/S, a biopharmaceutical company, develops therapeutics for unmet medical needs. The company develops TransCon growth hormone, which completed Phase III clinical trials for growth hormone deficiency. It also develops TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for achondroplasia. In addition, the company develops preclinical studies in the field of oncology for potential product candidates and evaluate systemic and localized delivery systems using its TransCon technologies. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark. .
Ascendis Pharma A/S in the news
Ascendis Pharma A/S : Articles of Association (Form 6-K)
IN BRIEF: Mineral & Financial investee Redcorp notes positive results
Ascendant Resources Announces After Tax NPV of $246 Million With an After Tax IRR of 55% From Its Preliminary Economic Assessment at Its Lagoa Salgada VMS Project in Portugal
Frequently asked questionsWhat percentage of Ascendis Pharma A/S is owned by insiders or institutions?
Currently 0.025% of Ascendis Pharma A/S shares are held by insiders and 99.098% by institutions. How many people work for Ascendis Pharma A/S?
Latest data suggests 482 work at Ascendis Pharma A/S. When does the fiscal year end for Ascendis Pharma A/S?
Ascendis Pharma A/S's fiscal year ends in December. Where is Ascendis Pharma A/S based?
Ascendis Pharma A/S's address is: Tuborg Boulevard 12, Hellerup, Denmark, 2900 What is Ascendis Pharma A/S's ISIN number?
Ascendis Pharma A/S's international securities identification number is: US04351P1012 What is Ascendis Pharma A/S's CUSIP number?
Ascendis Pharma A/S's Committee on Uniform Securities Identification Procedures number is: 04351P101
More guides on Finder
How to buy MiNK Therapeutics (INKT) stock when it goes public
Everything we know about the MiNK Therapeutics IPO, plus information on how to buy in.
How to buy Wetouch Technology (WETH) stock when it goes public
Everything we know about the Wetouch Technology IPO, plus information on how to buy in.
How to buy Life Time Group Holdings (LTH) stock when it goes public
Everything we know about the Life Time Group Holdings IPO, plus information on how to buy in.
How to buy Slinger Bag stock when it goes public
Everything we know about the Slinger Bag IPO, plus information on how to buy in.
How to buy NSTS Bancorp (NSTS) stock when it goes public
Everything we know about the NSTS Bancorp IPO, plus information on how to buy in.
How to buy Volcon (VLCN) stock when it goes public
Everything we know about the Volcon IPO, plus information on how to buy in.
How to buy Thomas James Homes (TJH) stock when it goes public
Everything we know about the Thomas James Homes IPO, plus information on how to buy in.
How to buy FGI Industries (FGI) stock when it goes public
Everything we know about the FGI Industries IPO, plus information on how to buy in.
How to buy Zhong Yang Financial Group (TOP) stock when it goes public
Everything we know about the Zhong Yang Financial Group IPO, plus information on how to buy in.
How to buy Exscientia Ltd (EXAI) stock when it goes public
Everything we know about the Exscientia Ltd IPO, plus information on how to buy in.
Ask an Expert